[Tolerance and clinical action of carbamazepine under in a new suspension form, in 38 children and adolescents aged from 2 to 18, with epilepsy, sometimes complicated by behavior and character disorders].
D000293:Adolescent; D002220:Carbamazepine / Q000008:administration & dosage*; D002605:Character; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D010554:Personality Disorders / Q000150:complications / Q000188:drug therapy*; D012640:Seizures / Q000188:drug therapy; D013535:Suspensions
D013535:Suspensions; D002220:Carbamazepine
Etude de la tolérance et de l'action clinique de la carbamazépine sous une présentation nouvelle de suspension chez 38 enfants et adolescents, âgés de 2 à 18 ans, atteints d'épilepsie associée parfois à des troubles du comportement et du caractère